Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharmacology > Drugs for Hyperlipidemia > Flashcards

Drugs for Hyperlipidemia Flashcards

1
Q

Statins

HMG-CoA reductase inhibitos

A 
Atorvastatin
Fluvastatin
Lovastatin
Pitavastatin
Pravastatin
Rosuvastatin
Simvastatin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Statins - MoA

A

HMG-CoA reductase converts HMG-CoA to mevalonic acid and is the rate-limiting enzyme in cholesterol biosynthesis. By competitively inhibiting this enzyme, statins reduce hepatic cholesterol biosynthesis and the amount of cholesterol available for incorporation into VLDL. This leads to compensatory increase in the number of hepatic LDL receptors, which increases hepatic uptake of LDL-C. Together, these actions cause a substantial reduction in LDL-C.

In patients with hypercholesterolemia, statins typically decrease LDL-C levels by 20% to 60%, whereas HDL-C levels are increased by up to 10%

The statins also reduce serum triglycerides but are usually not a sufficient treatment for hypertriglyceridemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Statins - Clinical use

A

Reduce blood cholesterol levels in persons with Hypercholesterolemia.

Slow the progression of atherosclerosis, reduce the risk of CHD and other atherosclerotic vascular diseases, and reduce cardiac mortality rate.

May protect against osteoporosis and certain forms of cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Statins - Adverse effects

A

GI problems; abdominal cramps, constipation, diarrhea, heartburn.

Hepatitis and elevated liver enzymes
Rhabdomyolysis
Muscle myopathy(earliest stage is myalgia, which consists of muscle ache or weakness without creatine kinase levels)

Myalgia can be followed by myositis or muscle inflammation accompanied by muscle pain, leakage of muscle creatine kinase into the plasma, and elevated creatine kinase levels

Myositis can eventually lead to rhabdomyolysis in which muscle cells disintegrate, thereby releasing myoglobin into the circulation

Myoglobin then accumulates in the kidneys and cause acute kidney failure

10-25% risk in incidence of diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Statins - Interactions

A

Atrovastatin, lovastatin and simvastatin are metabolized by CYP3A4, plasma levels increases strong by inhibitors of this isozyme; erythromycin, itraconazole, ritonavir

Fluvastatin is metabolized by CYP2C9, and its plasma levels may be increased by inhibitors of this CYP, including some NSAIDs

They increase warfarin levels slightly by inhibiting warfarin metabolism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Statins - Contraindications

A

Because statins , fibric acid derivatives, and niacin may cause myopathies, the combined use of drugs should be undertaken with greater caution using lower doses of each agent employed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which statins are used for mixed hyperlipidemia?

A

Atorvastation and Rosuvastatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Most potent statin

Second most potent satin

A

Rosuvastatin

Atorvastatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which statins crosses the blood brain barrier and can cause sleep disturbances?

A

Lovastatin and Simvastatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Lovastatin - Interactions

A

Should be taken with evening meal to facilitate its absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Bile Acid-Bindings Resins

A

Cholestyramine
Colestipol
Colesevelam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Bile Acid-Bindings Resins - MoA

A

After resins bind to bile acids, the bile acid-resin complex is excreted. This action prevents the enterohepatic cycling of bile acid and obligates the liver to synthesize replacement bile acid from cholesterol. To obtain more cholesterol for this purpose, the liver increases the number of LDL receptors. Then the levels of LDL-C in the blood are reduced as more cholesterol is delivered to the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Bile Acid-Bindings Resins - Clinical use

A

Hypercholesterolemia in pat who cannot tolerate other drugs and in patients who are young.

Chronic diarrhea due to bile acid malabsorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Bile Acid-Bindings Resins - Adverse effects

A 
Constipation
Fecal impaction
GI side effect, nausea, vomiting.
Irritation of the perianal area
Skin rash
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Bile Acid-Bindings Resins - Interactions

A

Decrease absorption of digoxin, thyroxin and warfarin.

Decreases absorption of fat soluble vitamins; A, D, E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cholestyramine and Colestipol - Interactions

A

Bind to digoxin, thyroxin, warfarin and other drugs. For this reason, it is best to take the resins 2 hours before or after taking other medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Ezetimibe - MoA

A

Absorbed from the intestines after oral adm, and mostly is converted to active ezetimibe-glucuronide. This metabolite is distributed by the circulation to the small intestines, where it localizes in the brush border and inhibits absorption of both biliary and dietary cholesterol. Acts by disrupting two protein, annexin-2 and caveolin-1, which mediates cholesterol transport in intestinal brush border cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Ezetimibe - Clinical use

A

Hypercholesterolemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Ezetimibe - Adverse effects

A

Increases serum hepatic transaminase levels
Headache
Myalgia

20
Q

Niacin - Classification

A

Vitamine B3

21
Q

Niacin - MoA

A

Inhibiting the formation and secretion of hepatic VLDL, the major carrier of plasma triglycerides and the precursor of LDL. The effect on VLDL secretion is caused by inhibition of lipolysis in adipose tissue. This action reduces the supply of circulating free fatty acids that the liver uses to synthesize triglycerides for incorporation into VLDL. The inhibition of lipolysis has been attributed to the binding of niacin to a G-protein coupled receptor in adipose tissue. Niacin decreases LDL-C levels and LDL associated with atherosclerosis, at the same time it increases HDL-C levels. Decreases lipoprotein (a)

22
Q

Niacin - Clinical use

A

Hypertriglycerdemia
Increase HDL-C levels in persons with abnormally low levels of this lipoprotein.

Primary hyperlipidemia
Mixed dyslipidemia
Reduce the risk of pancreatitis in pat with high triglyceride levels.

Reduces risk of myocardial infaction among men with hypercholesterolemia and atherosclerosis, and is decreased total mortality

23
Q

Niacin - Adverse effects and Interactions

A

Vasodilation and flushing of the skin accompanied by pruritus and a feeling of warmth and tingling.

Elevate serum transaminase levels and cause hepatitis

Gastric distress
Trigger peptic ulcers
Increase glucose levels, but well tolerated in diabetes.
Hyperuricemia and gout
Myopathy

Interactions:
Fibrates or statins increase risk of myopathy
Avoid in pt w: PUD, acute liver disease, Pregnancy, Arterial bleeding

24
Q

Fibric acid derivatives

A

Gemfibrozil

Fenofibrate

25
Q

Fibric acid derivatives - MoA

A

Reduce serum levels of triglycerides and LDL-C while rasing levels of HDL-C. They activate a receptor in cell nuclei that regulates gene transcription and is called peroxisome proliferator activated receptor-a. In the liver and elsewhere, PPAR-a increases the transcription of certain genes while inhibition transcription of others. The effect of fibrate on serum triglyceride levels is attributed to PPAR-a mediated expression of lipoprotein lipase. This enzyme is in the vascular endothelium and catalyzes the hydrolysis and removal of triglycerides from VLDL, thereby lowering triglyceride levels. PPAR-a activation also reduces the expression of an inhibitor of lipoprotein lipase, apolipoprotein C-III. The effects of fibrates on HDL-C are attributed to PPAR-a mediated expression of apoproteins A-I and A-II for HDL. PPAR-a also increases the expression of cholesterol transport proteins (ATP-binding cassette transporters A1 and G1) involved in reverse cholesterol transport.

26
Q

Fibric acid derivatives - Clinical use

A

Very high serum triglyceride levels (higher then 1500mg/dL) in order to prevent pancreatitis

Reduce the risk of developing Coronary Heart Disease in patients who have a triad of elevated LDL-C, low HDL-C, and elevated triglycerides, and whose lipidemia has not responded to lifestyle changes or other pharmacologic agents

Antiretroviral therapy

27
Q

Fibric acid derivatives - Adverse effects

A 
GI side effects
Blood cell deficiency 
Hypersensitivity reactions
Myopathy
Rhabdomyolysis
28
Q

Fibric acid derivatives - Contraindications

A

Given with statins
Hepatic/Renal disease
increased risk of gallstones

29
Q

Fibric acid derivatives - Interactions

A

Cholestyramine and colestipol must be separated by two hours because the resins reduce fibrate absorption

30
Q

Fenofibrate - MoA

A

Reduces serum LDL-C levels by increasing expression of hepatic LDL receptors and by increasing LDL receptor affinity, both via activation of PPAR-a. These actions increase the uptake of LDL-C by the liver and reduce serum LDL-C levels.

31
Q

Drugs for Familial Hypercholesterolemia

A

Lomitapide
Mipomersen
Evolocumab
Alirocumab

32
Q

Lomitapide - MoA

A

Act to reduce the production of VLDL in the liver

Inhibits the microsomal triglyceride transfer protein (MTTP), which is essential for VLDL assembly and secretion in the liver

33
Q

Lomitapide - Clinical use

A

Homozygous familial hypercholesterolemia

34
Q

Lomitapide - Adverse effects

A

GI side effects
Hepatic toxicity
Embryotoxicity

35
Q

Lomitapide - Contraindications

A

Pregnancy because it is embryotoxic

36
Q

Lomitapide - Interactions

A

Lomitapide decreases the absorption of fat-soluble vitamins A, D, and E, and omega-3 fatty acids. These nutrient should be supplemented in patients taking this drug

Inhibitors of CYP3A4 increases levels of Lomitapide

Lomitapide increases Warfarin levels

37
Q

Mipomersen - MoA

A

Act to reduce the production of VLDL in the liver

Binds to the messenger RNA for apo-B, preventing synthesis of apo B required for VLDL production in the liver.

38
Q

Mipomersen - Clinical use

A

Reduce LDL-C and apo B in persons with Homozygous familial hypercholesterolemia

39
Q

Mipomersen - Adverse effects

A 
Elevate serum transaminase levels
Injection site reactions
Flu-like symptoms
Nausea
Headache
40
Q

Evolocumab and Alirocumab - MoA

A

Monoclonal antibody to a protease enzyme that destroys LDL receptors in the liver. This enzyme is known as proproteins convertase subtilisin/kexin type 9 (PCSK9). By this mechanism, the hepatic uptake of LDL cholesterol is increased, and the serum cholesterol level falls.

41
Q

Evolocumab and Alirocumab - Clinical use

A

Homozygous or heterozygous familial hypercholesterolemia and for patients with demonstrated atherosclerotic cardiovascular disease who are not adequately treated with statins

42
Q

Evolocumab and Alirocumab - Adverse effects

A

Injection site reactions
Allergic reactions
Elevated levels of hepatic enzymes

43
Q

Drugs for Leptin Deficiency

A

Metreleptin

44
Q

Metreleptin - MoA

A

Binds to and activates the leptin receptor, leading to increase in insulin sensitivity and reduced food intake

45
Q

Metreleptin - Clinical use

A

Lipodystrophy

Indicated as replacement therapy (in addition to diet) for the complications of leptin deficiency in patients with congenital generalized or acquired generalized lipodystrophy

46
Q

Metreleptin - Adverse effects

A

Neutralizing antibodies and a risk of lymphoma

Pharmacology (55 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions